<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>anti-thymocyte globulin &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/anti-thymocyte-globulin/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 22 Jan 2026 16:14:23 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>anti-thymocyte globulin &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Anti-Thymocyte Globulin: Effective Across Ages in Aplastic Anemia</title>
		<link>https://bioengineer.org/anti-thymocyte-globulin-effective-across-ages-in-aplastic-anemia/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 22 Jan 2026 16:13:56 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[age-specific outcomes]]></category>
		<category><![CDATA[anti-thymocyte globulin]]></category>
		<category><![CDATA[anti-timosit globulin]]></category>
		<category><![CDATA[aplastik aneminin tedavi seç]]></category>
		<category><![CDATA[gerçek dünya verisi]]></category>
		<category><![CDATA[Immunosuppressive Therapy]]></category>
		<category><![CDATA[İşte bu içerik için uygun 5 etiket: **aplastik anemi tedavisi]]></category>
		<category><![CDATA[İşte bu yazı için 5 uygun etiket: **aplastic anemia]]></category>
		<category><![CDATA[real-world data** **Açıklama:** 1. **aplastic anemia:** Makalenin ana konusu olan hastalık. 2. **anti-thymocyte globulin (ATG):** Makalenin odaklandığı tedavi ajanı. 3. **]]></category>
		<category><![CDATA[uzun dönem tedavi sonuçları** **Açıklama:** 1. **aplastik anemi tedavisi:** Makalenin ana konusu]]></category>
		<category><![CDATA[yaşlı hasta tedavisi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/anti-thymocyte-globulin-effective-across-ages-in-aplastic-anemia/</guid>

					<description><![CDATA[Recent advancements in the treatment of aplastic anaemia reveal a significant breakthrough with the use of anti-thymocyte globulin (ATG). Particularly noteworthy is the newly published research that sheds light on the efficacy of ATG-based therapies in both elderly and younger adult demographics. This compelling data is drawn from the Dutch aplastic anaemia registry and emphasizes [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319347</post-id>	</item>
	</channel>
</rss>
